Symptom provocation studies in psychiatric disorders: Scientific value, risks, and future

Biological Psychiatry

Volumn 46, Issue 8, 1999, Pages 1060-1080

  D'Souza, D C ^a   Berman, R M ^a   Krystal, J H ^a   Charney, D S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Benefits; Bioethics; Psychiatry institutional review board; Risks; Safeguards; Symptom provocation

Indexed keywords

CONFERENCE PAPER; HUMAN; INSTITUTIONAL CARE; NEGATIVE SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROVOCATION; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; SYMPTOMATOLOGY;

EID: 0032870015     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00209-7     Document Type: Conference Paper

References (153)

1. M Abelson J Howes M.J George The conjunctival provocation test model of ocular allergy Utility for assessment of an ocular corticosteroid, loteprednol etabonate Ocular Pharmacol Ther 4 1998 533 542
2. A Abi-Dargham R Gil J Krystal Increased striatal dopamine transmission in schizophrenia Confirmation in a second cohort Am J Psychiatry 155 1998 761 767
3. Anand A, Charney DS, Cappiello A, Berman RM, Oren DA, Krystal JH (1997) Lamotrigine reduces the psychotomimetic but not the mood-elevating effects of ketamine in humans . 36th Annual Meeting, American College of Neuropsychopharmacology , pp 251.
4. N.E Anden S.G Butcher H Corrodi K Fuxe U Ungerstedt Receptor activity and turnover of dopamine and noradrenaline after neuroleptics Eur J Pharmacol 11 1970 303 314
5. N.C Andreasen Symptoms, signs, and diagnosis of schizophrenia Lancet 346 1995 477 481
6. B.M Angrist E Gershon The phenomenology of experimentally induced amphetamine psychosis—preliminary observations Biol Psychiatry 2 1970 95 107
7. B.M Angrist H.K Lee S Gershon The antagonism of amphetamine-induced symptomatology by a neuroleptic Am J Psychiatry 131 1974 817 819
8. B.M Angrist E Peselow J Rotrosen S Gershon Relationships between responses to dopamine agonists, psychopathology, neuroleptic treatment response, and need for neuroleptic maintenance in schizophrenic subjects B Angrist Recent Advances in Neuropsychopharmacology. Advances in Biosciences, Vol. 31 1981 Pergamon Oxford, New York 49 54
9. B.M Angrist E Peselow M Rubinstein J Corwin J Rotrosen Partial improvement in negative schizophrenic symptoms after amphetamine Psychopharmacology 78 1982 128 130
10. B Angrist E Peselow M Rubenstein A Wolkin J Rotrosen Amphetamine response and relapse risk after depot neuroleptic discontinuation Psychopharmacology 85 1985 277 283
11. B.M Angrist J Rotrosen S Gershon Differential effects of amphetamine and neuroleptics on negative versus positive symptoms in schizophrenia Psychopharmacology 72 1980 17 19
12. B.M Angrist B Shopsin S Gershon Comparative psychotomimetic effects of stereoisomers of amphetamine Nature 19 1971 152 153
13. A.F Arnsten Catecholamine regulation of the prefrontal cortex Psychopharmacology 11 1997 151 162
14. 1 receptor mechanisms in the cognitive performance of young adult and aged monkeys Psychopharmacology 116 1994 143 151
15. R Balcon W.C Maloy E Sowton Clinical use of atrial pacing test in angina pectoris Brit Med 3 1968 91
16. P.G Bardin G Sanderson B.S Robinson S.T Holgate D.A Tyrrell Experimental rhinovirus infection in volunteers Eur Resp J 9 1996 2250 2255
17. F.M Baroody S Ford D Proud A Kagey-Sobotka L Lichtenstein R.M Naclerio Relationship between histamine and physiological changes during the early response to nasal antigen provocation J Appl Physiol 86 1999 659 668
18. L.C Barr W.K Goodman C.J McDougle Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors Arch Gen Psychiatry 51 1994 309 317
19. D.S Bell The experimental production of amphetamine psychosis Arch Gen Psychiatry 29 1973 35 40
20. R Berman A Cappiello H Miller A Anand D Oren D Charney Catecholamine depletion induces a transient depressive reaction in unmedicated healthy subjects with a history of major depression New trait marker? Arch Gen Psychiatry 56 1999 395 403
21. M Birchwood P McGorry H Jackson Early intervention in schizophrenia Brit J Psychiatry 170 1997 2 5
22. H Blackburn The electrocardiogram during exercise (findings in bipolar chest leads of 1449 middle aged men, at moderate work levels) Circulation 34 1966 1034
23. E Bleuler Dementia Praecox and the Group of Schizophrenia (translated by J. Zinkin) 1950 International Universities Press New York
24. G Bousfield Angina pectoris Changes in electrocardiogram during paroxysm Lancet 2 1918 457
25. A Breier C.M Adler N Weisenfeld Effects of NMDA antagonism on striatal dopamine release in healthy subjects Application of a novel PET approach Synapse 29 1998 142 147
26. A Breier A.K Malhotra D.A Pinals N.I Weisenfeld D Pickar Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers Am J Psychiatry 154 1997 805 811
27. A Breier T.P Su R Saunders Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations Evidence from a novel positron emission tomography method Proc Natl Acad Sci 94 1997 2569 2574
28. Brock LL (1967): Stress testing incidents in work evaluation units in WEU subcommittee newsletter. American Heart Association, New York .
29. H Brodie D Murphy F Goodwin W Bunney Catecholamines and mania The effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism Clin Pharmacol Ther 12 1971 218 224
30. R.A Bruce Evaluation of functional capacity and exercise tolerance of cardiac patients Mod Concepts Cardiovasc Dis 25 1956 321
31. W Bunney H Brodie D Murphy F Goodwin Studies of alpha-methyl-para-tyrosine, l -DOPA, and l -tryptophan in depression and mania Am J Psychiatry 127 1971 7
32. W Bunney J Davis Norepinephrine in depressive reactions A review Arch Gen Psychiatry 13 1965 483 494
33. A Carlsson M Lindquist Effects of chlorpromazine or haloperidol formation of 3-methoxytyramine and normetanephrine in mouse brain Acta Pharmacol Toxicol 20 1964 140 144
34. A Carlsson M Lindquist T Magnusson 3,4-Dihydroxyphenylalanine and 5-hydroxy-tryptophan as reserpine antagonists Nature 180 1957 1200
35. Z Cesarec A.K Nyman Differential response to amphetamine in schizophrenia Acta Pscyhiatr Scand 71 1985 523 538
36. D.S Charney G.R Heninger A Breier Noradrenergic function in panic anxiety Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder Arch Gen Psychiatry 41 1984 751 763
37. G Cieslewicz G Juszczyk J Foremny Inhaled corticosteroid improves bronchial reactivity and decreases symptoms in patients with mitral stenosis Chest 114 1958 1070 1074
38. P.H Connell Amphetamine Psychoses. Maudsley, Monographs No. 5 1958 Oxford University Press London
39. A Coppen The biochemistry of affective disorders Brit J Psychiatry 113 1967 1237 1264
40. G Corssen E.F Domino Dissociative anesthesia further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581 Anesth Analg 45 1966 29 40
41. J.T Coyle The glutamatergic dysfunction hypothesis for schizophrenia Harvard Rev Psychiat 3 1996 241 253
42. T.J Crow J.F MacMillan A.L Johnson The Northwick Park study of first episodes of schizophrenia, II A randomized trial controlled trial of prophylactic neuroleptic treatment Brit J Psychiatry 148 1986 120 127
43. D.G Daniel D.R Weinberger D.W Jones The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia J Neurosci 11 1991 1907 1917
44. K.L Davis R.S Kahn G Ko M Davidson Dopamine in schizophrenia A review and reconceptualization Am J Psychiatry 148 1991 1474 1486
45. J.M Davis S Andriukaitis The natural course of schizophrenia and effective maintenance drug treatment J Clin Psychopharmacol 6 suppl 1 1986 2S 10S
46. D.C D’Souza D.S Charney J.H Krystal Glycine site agonists of the NMDA receptor A review CNS Drug Rev 1 1995 150 186
47. D’Souza DC, Gil R, Belger A, et al (1997): Glycine ketamine interactions in healthy humans. Annual Meeting of the American College of Neuropsychopharmacology, Hawaii .
48. e congres des Alienistes et Neurologie de Langue Fse, 503–513.
49. P Delgado D Charney L Price Serotonin function and the mechanism of antidepressant action Reversal of antidepressant induced remission by rapid depletion of plasma tryptophan Arch Gen Psychiatry 47 1990 411 418
50. J Edwards D Maude P.D McGorry S.M Harrigan J.T Cocks Prolonged recovery in first-episode psychosis Brit J Psychiatry 172 1998 107 116
51. M.H Ellestad R.H Startt Selvester F.S Mishlin F.W James K Mazumi History of stress testing R.W Reinhardt Stress Testing Principles and Practice 1996 FA Davis Company Philadelphia 1 9
52. M.H Ellestad R.H Startt Selvester F.S Mishlin F.W James K Mazumi Contraindications, Risks and Safety Precautions R.W Reinhardt Stress Testing Principles and Practice 1996 FA Davis Company Philadelphia 121 139
53. E.H Ellinwood Jr Effect of chronic methamphetamine intoxication in Rhesus monkeys Biol Psychiatry 3 1971 25 32
54. E.H Ellinwood Jr A Sudilovsky L.M Nelson Evolving behavior in the clinical and experimental amphetamine (model) psychosis Am J Psychiatry 130 1973 1088 1093
55. P.R Evans C Piesse Y.T Bak J.E Kellow Fructose-sorbitol malabsorption and symptom provocation in irritable bowel syndrome Relationship to enteric hypersensitivity and dysmotility Scand J Gastroenterol 33 1998 1158 1163
56. H Feil M Seigel Electrocardiographic changes during attacks of angina pectoris Am J Med Sci 1928 175 225
57. A.P Fitzpatrick R.J Lee L.M Epstein M.D Lesh S Eisenberg M.M Sheinman Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation Heart 76 1996 406 411
58. M Frieri J Therattil V Chavarria Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis Ann Allergy 81 1998 431 437
59. G Gardos J.O Cole Maintenance antipsychotic treatment therapy Is the cure worse than the disease Am J Psychiatry 133 1976 32 36
60. J Gerlach K Luhdorf The effect of l -dopa on young patients with simple schizophrenia treated with neuroleptic drugs Psychopharmacologia 44 1975 105 110
61. D.C Goff G Tsai J Levitt Placebo-controlled trial of d -cycloserine added to conventional neuroleptics Arch Gen Psychiatry 56 1999 21 27
62. S Goldhammer D Scherf Elektrokardiographische untersuchungen bei kranken mit angina pectoris Z Klinical Medicine 122 1932 134
63. H Gong Jr W.S Linn D.A Shamoo Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects Chest 110 1996 1229 1235
64. J.D Griffith J Cavanaugh J Held J Oates Experimental psychosis induced by the administration of d -amphetamine E Costa S Garattini Amphetamines and Related Compounds Proceedings of the Mario Negri Institute for Pharmacological Research, Milan, Italy 1970 Raven Press New York 897 905
65. J.D Griffith J Cavanaugh J Held J Oates Dextroamphetamine evaluation of psychomimetic properties in man Arch Gen Psychiatry 26 1972 17 100
66. J.D Griffith J Oates Paranoid episodes induced by drug Schizophrenia model? JAMA 205 1968 39 40
67. H.H Hecht Concepts of myocardial ischemia Arch Int Med 84 1949 711
68. U Heresco-Levy D.C Javitt M Ermilov C Mordel A Horowitz D Kelly Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia Brit J Psychiatry 169 1996 610 617
69. U Heresco-Levy D.C Javitt M Ermilov C Mordel G Silipo M Lichtenstein Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia Arch Gen Psychiatry 56 1999 29 36
70. J.M Hope E Callaway S.L Sands Intravenous pervitin and the psychopathology of schizophrenia Dis Nervous System 12 1951 67 72
71. O Hornykiewicz Dopamine (3-hydroxytyramine) and brain function Pharmacol Rev 18 1966 925 964
72. K Inanaga K Inoue H Tachibana M Oshima T Kotori Effect of l -DOPA in schizophrenia Folia Psychiatrica et Neurologica Japonica (Niigata) 26 1972 145 157
73. K Inanaga Y Nakazawa K Inoue Double-blind controlled study of l -DOPA therapy in schizophrenia Folia Psychiatrica et Neurologica Japonica (Niigata) 29 1975 123 142
74. D.S Janowsky J.M Davis Dopamine, psychomotor stimulants, and schizophrenia Effects of methylphenidate and the stereoisomers of amphetamine in schizophrenics Adv Biochem Psychopharmacol 12 1974 317 323
75. D.S Janowsky M.K El-Yousef J.M Davis H.J Sekerke Provocation of schizophrenic symptoms by intravenous administration of methylphenidate Arch Gen Psychiatry 28 1973 185 191
76. D.C Javitt S.R Zukin Recent advances in the PCP model of schizophrenia Am J Psychiatry 48 1991 1301 1308
77. D Jody J.A Lieberman S Geisler S Szymanski J.M Alvir Behavioral response to methylphenidate and treatment outcome in first episode schizophrenia Psychopharmacol Bull 26 1990 224 230
78. L Katz H Landt Effects of exercise on the 4-lead electrocardiogram its value in the study of coronary disease Am J Sci 189 1935 346
79. M Kayahara G Murakami Y Adachi Bronchial hypersensitivity and development of bronchial asthma in children with atopic dermatitis Arerugi 43 1994 759 765
80. Kegeles L, Zea-Ponce Y, Abi-Dargham A, et al (1998): Glutamate-dopamine interactions in humans: ketamine modulation of amphetamine-induced striatal dopamine release studied by SPECT imaging. Abstracts of the 37th Annual Meeting of the American College of Neuropsychopharmacology, Las Croabas, Puerto Rico , pp 186.
81. J.S Kim H.H Kornhuber W Schmid-Burgk B Holzmuller Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia Neurosci Lett 20 1980 379 382
82. Krystal JH, D’Souza DC, Petrakis I, et al (1999): NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies for neuropsychiatric disorders. Harvard Rev Psychiatry (in press).
83. Krystal JH, D’Souza DC, Karper L, et al (1999): Glutamate-dopamine interactions in humans: Interactive effects of subanesthetic ketamine and haloperidol. Psychopharmacology (in press).
84. J.H Krystal L.P Karper A Bennett Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans Psychopharmacology 135 1998 213 229
85. J.H Krystal L.P Karper J Seibyl Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans Psychomimetic, perceptual, cognitive and neuroendocrine responses Arch Gen Psychiatry 51 1994 199 214
86. A.C Lahti H.H Holcomb D.R Medoff C.A Tamminga Ketamine activates psychosis and alters limbic blood flow in schizophrenia Neuroreport 6 1995 869 872
87. A.C Lahti B Koffel D Laporte C.A Tamminga Subanesthetic doses of ketamine stimulate psychosis in schizophrenia Neuropsychopharmacology 13 1995 9 19
88. U.G Lalloo S Lim R DuBois P.J Barnes K.F Chung Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease Eur Resp J 11 1998 702 705
89. I.P Lapin G.F Oxenkrug Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect Lancet 1 1969 132 136
90. M Laruelle A Abi-Dargham C Van Dyke R Gil D.C D’Souza Increased synaptic dopamine release in drug free schizophrenic subjects Proc Natl Acad Sci USA 93 1996 9235 9240
91. M Laruelle A Abi-Dargham R Gil L Kegeles R Innis Increased dopamine transmission in schizophrenia Relationship to illness phases Biol Psychiatry 46 1999 56 72
92. W.J Lewis W.J Wilson Correlation of coronary arteriograms with Master’s test and treadmill test Rocky Mt Med J 68 1971 30
93. P.F Liddle Regional brain abnormalities associated with specific syndromes of persistent schizophrenic symptoms Clin Neuropharmacol 15 suppl 1 1992 401A 402A
94. J.A Lieberman J.M Kane J Alvir Provocative tests with psychostimulant drugs in schizophrenia Psychopharmacology 91 1987 415 433
95. J.A Lieberman J.M Kane D Gadaleta R Brenner M.S Lesser B Kinon Methylphenidate challenge as a predictor of relapse in schizophrenia Am J Psychiatry 141 1984 633 638
96. J.A Lieberman J.M Kane S Sarantakos Prediction of relapse in schizophrenia Arch Gen Psychiatry 44 1987 597 603
97. J.A Leiberman B.J Kinon A.D Loebel Dopaminergic mechanisms in idiopathic and drug-induced psychoses Schizophr Bull 16 1990 97 110
98. K.Y Little T.L Gay M Vore Predictors of response to high dose antipsychotics in chronic schizophrenics Psychiat Res 30 1989 1 9
99. E.D Luby J.S Gottlieb B.D Cohen G Rosenbaum E.F Domino Model psychoses and schizophrenia Am J Psychiatry 119 1959 61 67
100. A.K Malhotra D.A Pinals H Weingarten NMDA receptor function and human cognition The effects of ketamine in healthy volunteers Neuropsychopharmacology 14 1996 301 307
101. C.M Martin D McConahay Maximal treadmill exercise electrocardiography Correlation with coronary arteriography and cardiac hemodynamics Circulation 46 1972 956
102. T.H Marwick S Nakatani B Haluska J.D Thomas H.M Lever Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy Am J Cardiol 75 1995 805 809
103. A.M Master E.J Oppenheimer A simple exercise tolerance test for circulatory efficiency with standard tables for normal individuals Am J Med Sci 177 1929 223
104. C.J McDougle S.T Naylor D.J Cohen G.K Aghajanian G.R Heninger L.H Price Effects of tryptophan depletion in drug-free adults with autistic disorder Arch Gen Psychiatry 53 1996 993 1000
105. P.D McGorry J Edwards C Mihalopoulos S.M Harrigan H.J Jackson EPPIC An evolving system of early detection and optimal management Schizophr Bull 22 1996 305 326
106. H Miller P Delgado R Salomon Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression Arch Gen Psychiatry 53 1996 117 128
107. H Miller P Delgado R Salomon G Heninger D Charney Effects of alpha-methyl-para-tyrosine (AMPT) in drug-free depressed patients Neuropsychopharmacology 14 1996 151 157
108. M.E Missal Exercise tests and the electrocardiogram during panic attacks of angina pectoris Ann Int Med 11 1938 2018
109. M Najmi Selective cine coronary arteriography correlated with hemodynamic response to physical stress Dis Chest 54 1968 33
110. H Nyback G Sedvall Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues Eur J Pharmacol 10 1970 193 205
111. C Ogura T Nakao A Kishimoto T Okuma T Inagaki M Moitoike Effects of the biogenic amine precursor ( l -DOPA) on schizophrenia Jap J Clin Psychiatry 3 1976 1115 1124
112. J.S Olney N.B Farber Glutamate receptor dysfunction and schizophrenia Arch Gen Psychiatry 52 1995 998 1007
113. H.H Pennes Clinical reactions of schizophrenics to intravenous amytal, pervitin hydrochloride, mescaline sulfate, and d -lysergic acid diethylamide (LSD ) J Nerv Ment Dis 119 1954 95 112
114. A Randrup I Munkvad Stereotyped activities produced by amphetamine in several animal species and man Psychopharmacology 11 1966 300 310
115. A Randrup I Munkvad Biochemical, anatomical and psychological investigation of stereotyped behavior induced by amphetamines E Costa S Garattini Amphetamines and Related Compounds 1970 Raven Press New York 695 715
116. J.E.F Riseman J Waller M Brown The electrocardiogram during attacks of angina pectoris Its characteristics and diagnostic significance Am Heart J 19 1940 683
117. G.P Robb H Marks Postexercise electrocardiogram in arteriosclerotic heart disease JAMA 200 1967 110
118. P Rochinis H Blackburn Exercise test A survey of procedures, safety and litigation experience in approximately 170,000 tests JAMA 217 1971 1061
119. G Rylander Clinical and medico-criminological aspects of addiction to central stimulating drugs F Sjoqvist M Tottie Abuse of Central Stimulants 1969 Raven Press New York 251 273
120. S.L Satel J.H Krystal P.L Delgado T.R Kosten D.S Charney Tryptophan depletion and attenuation of cue-induced craving for cocaine Am J Psychiatry 152 1995 778 783
121. D Scherer N Kaltenbach Frequency of life-threatening complications associated with stress testing Deutsch Med Woschenschr 104 1979 1161
122. J Schildkraut The catecholamine hypothesis of affective disorders A review of supporting evidence Am J Psychiatry 122 1965 509 521
123. J Schiller Y Schiller G Stuart B Sakmann Calcium action potentials restricted to distal apical dendrites of rat neocortical pyramidal neurons J Physiol (London) 15 1997 605 616
124. L.T Sheffield Safety of exercise testing volunteer subjects The lipids research clinics’ prevalence study experience J Cardiovasc Rehab 2 1982 395 400
125. B Shopsin E Friedman S Gershon Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients Arch Gen Psychiatry 33 1976 811 891
126. B Shopsin S Gershon M.F Goldstein E Friedman S Wilk Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients Psychopharmacol Comm 1 1975 239 249
127. S.L Simon H Traube A preliminary study on the use of Methedrine in psychiatric diagnosis J Nerv Ment Dis 104 1946 593 596
128. C.W Slipman C.T Plastaras R.A Palmitier C.W Huston E.B Sterenfeld Symptom provocation of fluoroscopically guided cervical nerve root stimulation. Are dynatomal maps identical to dermatomal maps? Spine 23 1998 2235 2242
129. K Smith C Fairburn P Cowen Relapse of depression after rapid depletion of tryptophan Lancet 349 1997 915 919
130. S.H Snyder Amphetamine psychosis as a model schizophrenia mediated by catecholamines Am J Psychiatry 130 1972 61 67
131. S.H Snyder Catecholamines in the brain as mediators of amphetamine psychosis Arch Gen Psychiatry 27 1973 169 179
132. H Steck Le syndrome extrapyramidal erdiencephalique au cours des traitements au Largactil et au Serpasil Ann Med Psychol 112 1954 737 743
133. R.J Stuart N.H Ellestad National survey of exercise stress testing facilities Chest 77 1980 94
134. A Sudilovsky Effects of disulfiram on the amphetamine-induced behavioral syndrome in the cat as a model of psychosis Nida Res Monogr 3 1975 109 135
135. A Sudilovsky L Nelson E.H Ellinwood Jr Amphetamine dyskinesia A direct observational study in cats Drug Addiction 2 1976 17 37
136. G Tsai P Yang L.C Chung N Lange J.T Coyle d -Serine added to antipsychotics for the treatment of schizophrenia Biol Psychiatry 44 1999 1081 1089
137. D.P van Kammen J.J Boronow Dextroamphetamine diminishes negative symptoms in schizophrenia Int Clin Psychopharmacol 3 1988 111 121
138. D.P van Kammen W.E Bunney J.P Docherty d -Amphetamine-induced heterogenous changes in psychotic behavior in schizophrenia Am J Psychiatry 139 1982 991 997
139. D.P van Kammen J.P Docherty S.R Marder J.N Rayner W.E Bunney Jr Long-term pimozide pretreatment differentially affects behavioral responses to dextroamphetamine in schizophrenia. Further exploration of the dopamine hypothesis of schizophrenia Arch Gen Psychiatry 39 1982 275 281
140. D.P van Kammen J.P Docherty S.R Marder S.C Schulz L Dalton W.E Bunney Jr Antipsychotic effects of pimozide in schizophrenia. Treatment response prediction with acute dextroamphetamine response Arch Gen Psychiatry 39 1982 261 266
141. J.M Van Rossum The significance of dopamine receptor blockade for the action of neuroleptic drugs H Brill J.O Cole P Deniker H Hippius P.B Bradley Proceedings of the 5th International Congress of the Collegium Internationale Neuro-Psycho-Phamracologicum 1967 Excerpta Medica Foundation Amsterdam 321 329
142. 18F]fluorodeoxyglucose (FDG) Eur Neuropsychopharmacol 7 1997 9 24
143. C.R Ward J.C Gray J.J Gilroy R.A Kenny Midodrine A role in the management of neurocardiogenic syncope Heart 79 1998 45 49
144. Warfel D, Lahti AC, Michaelidis T, et al (1999): Follow-up of patients who receive challenge with ketamine as part of a research study. International Congress on Schizophrenia Research Abstracts pp 317.
145. D.R Weinberger K.F Berman R.F Zec Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence Arch Gen Psychiatry 43 1986 114 124
146. T.E Weltzin M.H Fernstrom J.D Fernstrom S.K Neuberger W.H Kaye Acute tryptophan depletion and increased food intake and irritability in bulimia nervosa Am J Psychiatry 152 1995 1668 1671
147. P Wood The effort test in angina pectoris Brit Heart J 12 1950 363
148. F.C Wood C.C Wolferth Angina pectoris The clinical and electrocardiographic phenomenon of an attack and their comparison with the effects of experimental temporary coronary occlusion Arch Int Med 47 1931 339
149. P.N.G Yu A Soffer Studies of electrocardiographic changes during exercise (modified double two-step test) Circulation 6 1952 183
150. D Young W.B Scoville Paranoid psychosis in narcolepsy and the possible dosages of benzedrine treatment Med Clin North Am 22 1938 673
151. A.R Yung P.D McGorry The initial prodrome in psychosis Descriptive and qualitative aspects Aust N Z J Psychiatry 30 1996 587 599
152. 3H)-Phencyclidine binding to specific brain receptor sites Psychopharmacol Bull 16 1980 59 62
153. 3H]phencyclidine binding in rat central nervous system Proc Natl Acad Sci USA 76 1979 5372 5376